Article in Impact loop.

“We have the first product in this field approved for hospital use. But AI is advancing rapidly, so there will be competition, which is great. The market is large, so there’s room for more players.”
Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman

Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman
Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine

Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine
Interview with Stratipath CTO Mattias Rantalainen about SwAIPP

Mattias Rantalainen, co-founder, CTO of Stratipath, and coordinator of SwAIPP (Sweden AI Precision Pathology), is being interviewed by Vinnova regarding innovation in precision medicine. “For us, building evidence around the solutions we develop is important. We collaborate internationally in several ongoing validation studies. We also gain synergies by conducting overlapping activities with a Nordic consortium. […]
MedTechLabs labs interview with Stratipath CEO, Fredrik Wetterhall,

MedTechLabs labs recently interviewed our CEO, Fredrik Wetterhall, discussing the rapid development from research to clinical use and the future trajectory of Stratipath.
”Inside Pathology” by Paige features Stratipath co-workers

”Inside Pathology” by Paige features Stratipath co-workers
Stratipath and Proscia Partnership Spotlighted in Pathology News

Stratipath and Proscia Partnership Spotlighted in Pathology News
”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”

More people are living longer with breast cancer – AI can be a game-changer.As October marks Breast Cancer Awareness Month, “Må Bra,” the Swedish wellness magazine, initiates this significant month with an exclusive interview featuring Stratipath co-founder Johan Hartman. The interview delves into topics such as groundbreaking treatments, precision medicine, and the game-changing potential of AI-powered […]
Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm.

Excited to share that Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm, contributing to the evolution of Sweden’s medical industry. Thanks to EU Startup News for the acknowledgement! ” This startup is working diligently to enhance treatment decisions and outcomes in cancer care. Their work exemplifies the transformative impact of technological […]
Stratipath co-founder Mattias Rantalainen is featured in this article by Healthcareineurope.com

Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and Proscia®, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.